On ECHEMI
Home > Drugs > Papillary cystadenocarcinoma
Papillary cystadenocarcinoma
Papillary cystadenocarcinoma is relatively rare among salivary gland tumors, accounting for about 5% to 7% of salivary gland epithelial tumors, and is often regarded as a subtype of adenocarcinoma. Eneroth et al. called this type of tumor "mucusproducing adenopapillary carcinoma". Papillary cystadenocarcinoma originates from the salivary gland duct epithelium.
  • Site of disease:

    mouth
  • Infectious :

    Not contagious
  • Frequent population:

    Age of onset: 12 to 72 years
  • Related symptoms:

    Smooth and tough spherical mass in the breast Thinning of gallbladder wall Breast mass Breast pain Breast redness, swelling, heat and pain
  • Concurrent disease:

Related Drugs
Pingyangmycin Hydrochloride for Injection
Indication: It is mainly used to treat lip cancer, tongue cancer, gum cancer, nasopharyngeal cancer and other cervical squamous cell carcinomas.
Manufacturer:

Han Hui Pharmaceuticals Company Limited

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.